Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
Matteo Piga, Laurent Arnaud
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 243-243
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Functional consequence of Iron dyshomeostasis and ferroptosis in systemic lupus erythematosus and lupus nephritis
Laurence Morel, Yogesh Scindia
Clinical Immunology (2024) Vol. 262, pp. 110181-110181
Closed Access | Times Cited: 8
Systemic Lupus Erythematosus: How Machine Learning Can Help Distinguish between Infections and Flares
Iciar Usategui‐Martín, Yoel Arroyo, Ana Torres, et al.
Bioengineering (2024) Vol. 11, Iss. 1, pp. 90-90
Open Access | Times Cited: 7
Identification of Diagnostic Biomarkers in Systemic Lupus Erythematosus Based on Bioinformatics Analysis and Machine Learning
Zhihang Jiang, Mengting Shao, Xinzhu Dai, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 32
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study
Matteo Piga, Elisabetta Chessa, Eric F. Morand, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e441-e449
Open Access | Times Cited: 29
Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force
Julien Blaess, Sophie Geneton, Thibaut Goepfert, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e004171-e004171
Open Access | Times Cited: 6
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial
Joan T. Merrill, Yoshiya Tanaka, David D’Cruz, et al.
Arthritis & Rheumatology (2024)
Open Access | Times Cited: 6
Targeting Nanotherapeutics for Highly Efficient Diagnosis and Treatment of Systemic Lupus Erythematosus through Regulation of Immune Response
Ting Liu, Zhiming Lin, Xi Zhang, et al.
Small Science (2025)
Open Access
Prediction of Lupus Classification Criteria via Generative AI Medical Record Profiling
Shantikumar V. Nair, Gerald H. Lushington, Mohan Purushothaman, et al.
BioTech (2025) Vol. 14, Iss. 1, pp. 15-15
Open Access
Introductory Chapter: Systemic Lupus Erythematosus – Basics and Developments
Mohammad Yusuf Hasan, Rizwan Ahmad
IntechOpen eBooks (2025)
Closed Access
Diagnosis and activity prediction of SLE based on serum Raman spectroscopy combined with a two-branch Bayesian network
Qianxi Xu, Xue Wu, Xinya Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
GC/MS and LC/MS serum metabolomic analysis of Chinese LN patients
Wei Wang, Jun Kou, Jie Long, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Cellular Response against Oxidative Stress, a Novel Insight into Lupus Nephritis Pathogenesis
Corina Daniela Ene, Simona Roxana Georgescu, Mircea Tampa, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 8, pp. 693-693
Open Access | Times Cited: 31
Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study
Tomas Walhelm, Iva Gunnarsson, Rebecca Heijke, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study
Aurélien Schlencker, Laurent Messer, M. Ardizzone, et al.
Lupus Science & Medicine (2022) Vol. 9, Iss. 1, pp. e000700-e000700
Open Access | Times Cited: 20
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study
Alberto Floris, Elisabetta Chessa, Gian Domenico Sebastiani, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002701-e002701
Open Access | Times Cited: 18
Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications
Anjali Yennemadi, Joseph Keane, Gina Leisching
Lupus (2023) Vol. 32, Iss. 5, pp. 603-611
Open Access | Times Cited: 11
Viewpoint on anifrolumab in patients with systemic lupus erythematosus and a high unmet need in clinical practice
Yoshiya Tanaka
RMD Open (2023) Vol. 9, Iss. 3, pp. e003270-e003270
Open Access | Times Cited: 10
Total Glucosides of Paeonia lactiflora for Safely Reducing Disease Activity in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Yifan Chen, Liuding Wang, Yu Cao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver’s Seat in Their Disease Monitoring?
Ioannis Parodis, Paul Studenic
Journal of Clinical Medicine (2022) Vol. 11, Iss. 2, pp. 340-340
Open Access | Times Cited: 16
Accurate Machine Learning Model to Diagnose Chronic Autoimmune Diseases Utilizing Information From B Cells and Monocytes
Yuanchen Ma, Jieying Chen, Tao Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Biomarkers for systemic lupus erythematosus: A scoping review
Su‐jie Zhang, R.C. Xu, Longli Kang
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 10
Open Access | Times Cited: 2
Challenges in Diagnosis and Management of SLE in Africa: An Online Survey
Farhanah Paruk, Dzifa Dey, Anisa Mosam, et al.
ACR Open Rheumatology (2024)
Open Access | Times Cited: 2
JAK inhibitors in systemic lupus erythematosus: Translating pathogenesis into therapy
Gabriela Ceobanu, Christopher J Edwards
Lupus (2024) Vol. 33, Iss. 13, pp. 1403-1415
Closed Access | Times Cited: 2
Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice
Kuan‐Ju Chen, Jimin Zhang, Daniel LaSala, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician
Teresa Semalulu, Achieng Tago, Kevin Zhao, et al.
ImmunoTargets and Therapy (2023) Vol. Volume 12, pp. 175-186
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top